Dengue Vaccine Strategy in India Influenced by Discovery of All Four Strains
New findings reveal all four dengue virus serotypes are circulating in India, with DENV-2 dominant, a discovery that will influence the country's upcoming vaccine strategy. This comes as questions are raised about the comprehensive effectiveness and challenges of a 12,000 Rupee dengue vaccine in the region.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)Sources
Ahead of dengue vaccine rollout, all 4 strains found in circulation
India's first dengue virus mapping shows all four serotypes circulating in eight states. This finding could influence the country's upcoming dengue vaccine strategy. Researchers found DENV-2 to be the dominant circulating strain across the nation. Concurrent infections with multiple strains are linked to more severe dengue disease. Continuous molecular surveillance is essential for monitoring virus circulation and guiding policy.
By ANUJA JAISWAL
Read full article →Why a Rs 12,000 vaccine isn’t the silver bullet against dengue in India
By Rajib Dasgupta
Read full article →
